MENU
+Compare
RLMD
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$4.06
Change
+$0.02 (+0.50%)
Capitalization
297.73M

RLMD Relmada Therapeutics Chart, History Price & Graph

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

RLMD
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLMD showed earnings on November 13, 2025. You can read more about the earnings report here.
View a ticker or compare two or three
RLMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

RLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
-8.48%
SYRE - RLMD
36%
Loosely correlated
-0.91%
ENSC - RLMD
31%
Poorly correlated
-4.57%
PRTC - RLMD
31%
Poorly correlated
N/A
AVXL - RLMD
31%
Poorly correlated
-3.40%
ZVRA - RLMD
29%
Poorly correlated
-2.10%
More